Aldeyra Therapeutics, Inc. (ALDX)

1.48 0.00 (0.00%) USD  |  NASDAQ  |  Sep 04, 16:00
1.48 0.00 (0.00%) After-Hours: 20:00
More

Aldeyra Therapeutics Cash and Short Term Investments (Annual) : 70.04M for Dec. 31, 2025

Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for ALDX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 2011. Start Trial.
Date Value
December 31, 2025 70.04M
December 31, 2024 101.15M
December 31, 2023 142.82M
December 31, 2022 174.30M
December 31, 2021 104.79M
December 31, 2020 52.86M
December 31, 2019 45.36M
December 31, 2018 93.60M
Date Value
December 31, 2017 42.95M
December 31, 2016 24.91M
December 31, 2015 27.59M
December 31, 2014 8.527M
December 31, 2013 3.262M
December 31, 2012 1.224M
December 31, 2011 0.251M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Arrowhead Pharmaceuticals, Inc. 919.37M
Oncolytics Biotech, Inc. 5.202M
Sangamo Therapeutics, Inc. 20.95M
Sarepta Therapeutics, Inc. 939.65M
Anixa Biosciences, Inc. 15.17M